$BMTI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMIMETIC THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOMIMETIC THERAPEUTICS, INC.. Get notifications about new insider transactions in BIOMIMETIC THERAPEUTICS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 8 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.77 | 300 | 2,931 | 917,790 | 918.1 K to 917.8 K (-0.03 %) |
| Jul 31 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.76 | 100 | 976 | 918,090 | 918.2 K to 918.1 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.95 | 200 | 1,990 | 918,190 | 918.4 K to 918.2 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.94 | 17 | 169 | 918,390 | 918.4 K to 918.4 K (0.00 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.93 | 283 | 2,810 | 918,407 | 918.7 K to 918.4 K (-0.03 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.92 | 200 | 1,984 | 918,690 | 918.9 K to 918.7 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.91 | 200 | 1,982 | 918,890 | 919.1 K to 918.9 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.90 | 200 | 1,980 | 919,090 | 919.3 K to 919.1 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.85 | 100 | 985 | 919,290 | 919.4 K to 919.3 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.84 | 148 | 1,456 | 919,390 | 919.5 K to 919.4 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.83 | 52 | 511 | 919,538 | 919.6 K to 919.5 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.79 | 200 | 1,958 | 919,590 | 919.8 K to 919.6 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.77 | 200 | 1,954 | 919,790 | 920 K to 919.8 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.76 | 100 | 976 | 919,990 | 920.1 K to 920 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.75 | 100 | 975 | 920,090 | 920.2 K to 920.1 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.72 | 200 | 1,944 | 920,190 | 920.4 K to 920.2 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.70 | 100 | 970 | 920,390 | 920.5 K to 920.4 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.68 | 300 | 2,904 | 920,490 | 920.8 K to 920.5 K (-0.03 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.65 | 89 | 859 | 920,790 | 920.9 K to 920.8 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.64 | 100 | 964 | 920,879 | 921 K to 920.9 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.63 | 11 | 106 | 920,979 | 921 K to 921 K (0.00 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.62 | 5 | 48 | 920,990 | 921 K to 921 K (0.00 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.59 | 195 | 1,870 | 920,995 | 921.2 K to 921 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 10.00 | 100 | 1,000 | 921,190 | 921.3 K to 921.2 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.98 | 100 | 998 | 921,290 | 921.4 K to 921.3 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.96 | 100 | 996 | 921,390 | 921.5 K to 921.4 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.95 | 100 | 995 | 921,490 | 921.6 K to 921.5 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.94 | 200 | 1,988 | 921,590 | 921.8 K to 921.6 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.91 | 200 | 1,982 | 921,790 | 922 K to 921.8 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.89 | 300 | 2,967 | 921,990 | 922.3 K to 922 K (-0.03 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.88 | 200 | 1,976 | 922,290 | 922.5 K to 922.3 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.87 | 300 | 2,961 | 922,490 | 922.8 K to 922.5 K (-0.03 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.86 | 400 | 3,944 | 922,790 | 923.2 K to 922.8 K (-0.04 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.85 | 300 | 2,955 | 923,190 | 923.5 K to 923.2 K (-0.03 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.84 | 200 | 1,968 | 923,490 | 923.7 K to 923.5 K (-0.02 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.83 | 100 | 983 | 923,690 | 923.8 K to 923.7 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.82 | 100 | 982 | 923,790 | 923.9 K to 923.8 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.79 | 100 | 979 | 923,890 | 924 K to 923.9 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.76 | 100 | 976 | 923,990 | 924.1 K to 924 K (-0.01 %) |
| Jul 20 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.74 | 100 | 974 | 924,090 | 924.2 K to 924.1 K (-0.01 %) |
| Jul 06 2009 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | P | 8.50 | 205 | 1,743 | 2,255 | 2.1 K to 2.3 K (+10.00 %) |
| Jul 06 2009 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | P | 8.50 | 125 | 1,063 | 1,375 | 1.3 K to 1.4 K (+10.00 %) |
| Jul 06 2009 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | P | 8.50 | 205 | 1,743 | 2,255 | 2.1 K to 2.3 K (+10.00 %) |
| Jul 06 2009 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | P | 8.50 | 3,160 | 26,860 | 4,760 | 1.6 K to 4.8 K (+197.50 %) |
| Jul 06 2009 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | P | 8.50 | 3,535 | 30,048 | 8,885 | 5.4 K to 8.9 K (+66.07 %) |
| Jul 06 2009 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | P | 8.50 | 944 | 8,024 | 10,244 | 9.3 K to 10.2 K (+10.15 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.48 | 11 | 104 | 924,190 | 924.2 K to 924.2 K (0.00 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.47 | 400 | 3,788 | 924,201 | 924.6 K to 924.2 K (-0.04 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.46 | 100 | 946 | 924,601 | 924.7 K to 924.6 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.42 | 100 | 942 | 924,701 | 924.8 K to 924.7 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.41 | 200 | 1,882 | 924,801 | 925 K to 924.8 K (-0.02 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.40 | 200 | 1,880 | 925,001 | 925.2 K to 925 K (-0.02 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.38 | 89 | 835 | 925,201 | 925.3 K to 925.2 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.37 | 195 | 1,827 | 925,290 | 925.5 K to 925.3 K (-0.02 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.36 | 196 | 1,835 | 925,485 | 925.7 K to 925.5 K (-0.02 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.34 | 400 | 3,736 | 925,681 | 926.1 K to 925.7 K (-0.04 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.33 | 209 | 1,950 | 926,081 | 926.3 K to 926.1 K (-0.02 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.31 | 200 | 1,862 | 926,290 | 926.5 K to 926.3 K (-0.02 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.30 | 320 | 2,976 | 926,490 | 926.8 K to 926.5 K (-0.03 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.29 | 200 | 1,858 | 926,810 | 927 K to 926.8 K (-0.02 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.27 | 80 | 742 | 927,010 | 927.1 K to 927 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.25 | 100 | 925 | 927,090 | 927.2 K to 927.1 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.50 | 200 | 1,900 | 927,190 | 927.4 K to 927.2 K (-0.02 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.44 | 100 | 944 | 927,390 | 927.5 K to 927.4 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.41 | 100 | 941 | 927,490 | 927.6 K to 927.5 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.37 | 100 | 937 | 927,590 | 927.7 K to 927.6 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.32 | 18 | 168 | 927,690 | 927.7 K to 927.7 K (0.00 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.30 | 82 | 763 | 927,708 | 927.8 K to 927.7 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.28 | 300 | 2,784 | 927,790 | 928.1 K to 927.8 K (-0.03 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.26 | 200 | 1,852 | 928,090 | 928.3 K to 928.1 K (-0.02 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.25 | 500 | 4,625 | 928,290 | 928.8 K to 928.3 K (-0.05 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.24 | 100 | 924 | 928,790 | 928.9 K to 928.8 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.23 | 100 | 923 | 928,890 | 929 K to 928.9 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.22 | 100 | 922 | 928,990 | 929.1 K to 929 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.21 | 200 | 1,842 | 929,090 | 929.3 K to 929.1 K (-0.02 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.19 | 100 | 919 | 929,290 | 929.4 K to 929.3 K (-0.01 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.17 | 300 | 2,751 | 929,390 | 929.7 K to 929.4 K (-0.03 %) |
| Jul 02 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.16 | 500 | 4,580 | 929,690 | 930.2 K to 929.7 K (-0.05 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.63 | 2,160 | 7,841 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.63 | 563 | 2,044 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.63 | 1,125 | 4,084 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.63 | 1,125 | 4,084 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.63 | 563 | 2,044 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.63 | 563 | 2,044 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.63 | 563 | 2,044 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.63 | 563 | 2,044 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.63 | 1,125 | 4,084 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.63 | 563 | 2,044 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.63 | 1,125 | 4,084 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 563 | 1,954 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 1,125 | 3,904 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 1,688 | 5,857 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 563 | 1,954 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 563 | 1,954 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 563 | 1,954 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 563 | 1,954 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 1,125 | 3,904 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 563 | 1,954 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 563 | 1,954 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 563 | 1,954 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 563 | 1,954 | 0 | |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.63 | 2,160 | 7,841 | 57,285 | 55.1 K to 57.3 K (+3.92 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.63 | 563 | 2,044 | 55,125 | 54.6 K to 55.1 K (+1.03 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.63 | 1,125 | 4,084 | 54,563 | 53.4 K to 54.6 K (+2.11 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.63 | 1,125 | 4,084 | 53,438 | 52.3 K to 53.4 K (+2.15 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.63 | 563 | 2,044 | 52,313 | 51.8 K to 52.3 K (+1.09 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.63 | 563 | 2,044 | 51,750 | 51.2 K to 51.8 K (+1.10 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.63 | 563 | 2,044 | 51,188 | 50.6 K to 51.2 K (+1.11 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.63 | 563 | 2,044 | 50,625 | 50.1 K to 50.6 K (+1.12 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.63 | 1,125 | 4,084 | 50,063 | 48.9 K to 50.1 K (+2.30 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.63 | 563 | 2,044 | 48,938 | 48.4 K to 48.9 K (+1.16 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.63 | 1,125 | 4,084 | 48,375 | 47.3 K to 48.4 K (+2.38 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 563 | 1,954 | 47,250 | 46.7 K to 47.3 K (+1.21 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 1,125 | 3,904 | 46,688 | 45.6 K to 46.7 K (+2.47 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 1,688 | 5,857 | 45,563 | 43.9 K to 45.6 K (+3.85 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 563 | 1,954 | 43,875 | 43.3 K to 43.9 K (+1.30 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 563 | 1,954 | 43,313 | 42.8 K to 43.3 K (+1.32 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 563 | 1,954 | 42,750 | 42.2 K to 42.8 K (+1.33 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 563 | 1,954 | 42,188 | 41.6 K to 42.2 K (+1.35 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 1,125 | 3,904 | 41,625 | 40.5 K to 41.6 K (+2.78 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 563 | 1,954 | 40,500 | 39.9 K to 40.5 K (+1.41 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 563 | 1,954 | 39,938 | 39.4 K to 39.9 K (+1.43 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 563 | 1,954 | 39,375 | 38.8 K to 39.4 K (+1.45 %) |
| Jun 30 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 563 | 1,954 | 38,813 | 38.3 K to 38.8 K (+1.47 %) |
| Jun 29 2009 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Buy | P | 8.50 | 508 | 4,318 | 8,508 | 8 K to 8.5 K (+6.35 %) |
| Jun 29 2009 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 8.50 | 343,406 | 2,918,951 | 3,720,065 | 3.4 M to 3.7 M (+10.17 %) |
| Jun 22 2009 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Option Exercise | A | 9.95 | 10,653 | 105,997 | 10,653 | |
| Jun 22 2009 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Option Exercise | A | 9.95 | 10,653 | 105,997 | 10,653 | |
| Jun 22 2009 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | A | 9.95 | 10,653 | 105,997 | 10,653 | |
| Jun 22 2009 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Option Exercise | A | 9.95 | 10,653 | 105,997 | 10,653 | |
| Jun 22 2009 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Option Exercise | A | 9.95 | 10,653 | 105,997 | 10,653 | |
| Jun 18 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.00 | 1,745 | 15,705 | 930,190 | 931.9 K to 930.2 K (-0.19 %) |
| Jun 18 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.01 | 200 | 1,802 | 931,935 | 932.1 K to 931.9 K (-0.02 %) |
| Jun 18 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.03 | 600 | 5,418 | 932,135 | 932.7 K to 932.1 K (-0.06 %) |
| Jun 18 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.04 | 428 | 3,869 | 932,735 | 933.2 K to 932.7 K (-0.05 %) |
| Jun 18 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.05 | 27 | 244 | 933,163 | 933.2 K to 933.2 K (0.00 %) |
| Jun 18 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.00 | 3,000 | 27,000 | 933,190 | 936.2 K to 933.2 K (-0.32 %) |
| Jun 05 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.12 | 200 | 1,824 | 936,190 | 936.4 K to 936.2 K (-0.02 %) |
| Jun 05 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.11 | 600 | 5,466 | 936,390 | 937 K to 936.4 K (-0.06 %) |
| Jun 05 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.09 | 100 | 909 | 936,990 | 937.1 K to 937 K (-0.01 %) |
| Jun 05 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.09 | 900 | 8,181 | 937,090 | 938 K to 937.1 K (-0.10 %) |
| Jun 05 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.06 | 200 | 1,812 | 937,990 | 938.2 K to 938 K (-0.02 %) |
| Jun 05 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.05 | 100 | 905 | 938,190 | 938.3 K to 938.2 K (-0.01 %) |
| Jun 05 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.02 | 200 | 1,804 | 938,290 | 938.5 K to 938.3 K (-0.02 %) |
| Jun 05 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.00 | 700 | 6,300 | 938,490 | 939.2 K to 938.5 K (-0.07 %) |
| Jun 05 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.00 | 2,731 | 24,579 | 939,190 | 941.9 K to 939.2 K (-0.29 %) |
| Jun 05 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.05 | 100 | 905 | 941,921 | 942 K to 941.9 K (-0.01 %) |
| Jun 05 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.06 | 124 | 1,123 | 942,021 | 942.1 K to 942 K (-0.01 %) |
| Jun 05 2009 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 9.07 | 45 | 408 | 942,145 | 942.2 K to 942.1 K (0.00 %) |
| Apr 08 2009 | BMTI | BIOMIMETIC THERAPE ... | Ehrlich Christopher B | Director | Buy | P | 8.50 | 941,177 | 8,000,005 | 941,177 | 0 to 941.2 K |